PCI Success vs Meds-Only in Diabetes May Depend on LDL-C Control PCI Success vs Meds-Only in Diabetes May Depend on LDL-C Control

PCI and LDL-lowering therapy work as a team to cut clinical risk in patients with diabetes and stable coronary disease, but succeed only if LDL-C goals are met; not so for CABG, suggests an analysis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news